close
close

ROCHE-Tochter Genentech has had a significant impact

ROCHE-Tochter Genentech has had a significant impact

The US Department of Justice has developed through Genentech, on a ROCHE day, the care for a two-year injection treatment for patients with multiple sclerosis. Obwohl…